×
0 0 0 0 0 0.00833333333333334 0.00833333333333334 0.00833333333333334
Stockreport

Capricor Trial Failure In Heart Disease Might Offer Another Opportunity [Seeking Alpha]

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: Seeking Alpha
Last capricor therapeutics earnings: 8/9 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Summary On Friday Capricor Therapeutics (NASDAQ: CAPR ) announced that it had failed a mid-stage trial using its cell therapy treatment on patients with heart attacks. The company suffered a huge setback and the stock tanked 62% on the failed results. Failed Phase 2 Trial The phase 2 trial that Caprictor Therapeutics ran was known as the ALLSTAR trial. It recruited a total of 142 patients that had experienced a major heart attack with residual cardiac function. The company stated that the trial had demonstrated a low probability of achieving the primary endpoint. Which is the reason why the shares crashed the way they did on Friday. The primary endpoint was to see a statistical significance over a 12-month period change percentage from baseline using an MRI. Patients were treated with cell therapy known as CAP-1002. The six month analysis p-value was concluded to be at p = 0.05 which is not statistically significant. With the stock falling 62% it knocked down the stock [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CAPR alerts

from News Quantified
Opt-in for
CAPR alerts

from News Quantified